title: Localized prostate cancer: quality of life meets Whitmore's legacy.
authors.forename: Carlos
authors.initials: C
authors.lastname: Bermejo
authors.forename: Alan R
authors.initials: AR
authors.lastname: Kristal
authors.forename: Steven B
authors.initials: SB
authors.lastname: Zeliadt
authors.forename: Scott
authors.initials: S
authors.lastname: Ramsey
authors.forename: Ian M
authors.initials: IM
authors.lastname: Thompson
mesh_terms: D003657:Decision Making; D018450:Disease Progression; D018572:Disease-Free Survival; D042241:Early Diagnosis; D005242:Fecal Incontinence / Q000209:etiology*; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods / Q000592:standards*; D010358:Patient Participation; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000009:adverse effects*; D011471:Prostatic Neoplasms / Q000276:immunology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D011788:Quality of Life; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects*; D018570:Risk Assessment; D014549:Urinary Incontinence / Q000209:etiology*
chemical_list: D017430:Prostate-Specific Antigen